# Neomorph

**Canonical:** https://apis.io/providers/neomorph/  
**Website:** https://neomorph.com/  
**APIs profiled:** 2

Neomorph, Inc. is a venture-backed, clinical-stage biotechnology company headquartered at 5590 Morehouse Drive in San Diego, California, founded in 2020 to design molecular glue degraders — small molecules that bind an E3 ubiquitin ligase, reshape it into a new "neomorphic" surface, and recruit disease-causing proteins to the proteasome for destruction. The approach targets the roughly 85% of the human proteome considered undruggable by conventional small molecules because it needs no traditional binding pocket. Neomorph's platform reaches beyond cereblon to hundreds of E3 ligases and multiple proprietary degrons, which the company describes as the largest proprietary molecular glue target space in the field. Its lead programme, NEO-811, targets ARNT/HIF-1β in clear cell renal cell carcinoma and entered a Phase 1/2 trial in February 2026; the rest of the pipeline spans undisclosed solid tumors plus partnered oncology/immunology, neurology and cardiometabolic/rare disease targets. The company closed a $109 million Series A in December 2020 and a $100 million Series B in April 2026, and runs multi-target discovery collaborations with Novo Nordisk (February 2024), Biogen (October 2024) and AbbVie (January 2025). Philip Chamberlain, DPhil is CEO and Robert J. Hugin was appointed Chairman of the Board in May 2026. Neomorph runs no developer program and publishes no product API, developer portal, API reference, SDK or pricing. The only machine-readable surface reachable without credentials is the WordPress REST content API behind neomorph.com, catalogued here.

## Kin Score — 34.3 / 100 (thin)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 34.3).

| Facet | Score |
|---|---|
| Discoverability | 75.9 |
| Contract Quality | 52.4 |
| Governance | 18.2 |
| Contract Governance | 18.2 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 13.7 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 48.8 (matched via tags).

## Agent readiness — 21.8 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | bearer |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | no |
| Rate Limit Signal | documented |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Open access — onboarding: open, pricing: unknown, trial: no (confidence: medium).

## APIs (12)

- **Neomorph Pages API** — Corporate pages — About, Platform, Pipeline, Publications, Patients, Careers, News, Contact and the policy set (15 published at harvest time, including the NEO-811 programme page).
- **Neomorph Publications API** — Publications custom post type — the peer-reviewed molecular glue and targeted protein degradation literature Neomorph's founders and scientists authored (11 published at harvest...
- **Neomorph Team API** — Team custom post type and its team_category taxonomy — management, board of directors and scientific founders (19 people across 4 registered categories at harvest time).
- **Neomorph Media API** — Media library — team portraits, pipeline and platform figures, and press assets (111 attachments at harvest time).
- **Neomorph Comments API** — Comment collection. Registered and anonymously reachable, but empty — no post on this deployment carries comments.
- **Neomorph Search API** — Cross-content search across every publicly queryable object type on the deployment (post, page, team, resource).
- **Neomorph Discovery API** — Route, post-type, taxonomy and status discovery documents — the 432-route, 23-namespace index the deployment publishes about itself.
- **Neomorph oEmbed API** — oEmbed 1.0 provider endpoint for neomorph.com permalinks.
- **Neomorph Categories API** — News taxonomy. Two terms are registered on this deployment: Press Release (13 posts) and In The Media (1 post).
- **Neomorph Posts API** — News archive - Neomorph press releases and media coverage (14 published at harvest time, spanning the December 2020 $109M Series A through the May 2026 appointment of Robert J. ...
- **Neomorph Tags API** — The post_tag taxonomy is registered and anonymously reachable but empty - no term has been created on this deployment.
- **Neomorph Team Categories API** — team_category taxonomy grouping the Team collection. Four terms are registered: Management (11), Board of Directors (7), Scientific Founders (4) and Scientific Advisory Board (0).

## Security (2)

- **Neomorph Authentication** — 0 schemes
- **Neomorph Domain Security** — TLSv1.3 · HSTS · DMARC

## Plans (1)

- **Neomorph Plans Pricing**

## Tags

Company, Biotechnology, Pharmaceuticals, Drug Discovery, Targeted Protein Degradation, molecular-glue, Oncology, Immunology, Rare Disease, Clinical Trials, Life Sciences, content-api

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/neomorph/). Scores are computed from the provider's own public artifacts under a published rubric.